Atezolizumab + Chemo After Surgery Does Not Improve Survival for Triple-Negative Breast Cancer
Similar findings seen in subgroups, including those with node-positive disease and patients with PD-L1-positive cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.